{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:43:41Z","timestamp":1793835821461,"version":"4.6.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-024-03472-5","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T03:39:55Z","timestamp":1726285195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli"],"prefix":"10.1186","volume":"24","author":[{"given":"Taha","family":"Golpasand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Keshvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Behzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,14]]},"reference":[{"key":"3472_CR1","doi-asserted-by":"crossref","unstructured":"Vollset, S.E.; Ababneh, H.S.; Abate, Y.H.; Abbafati, C.; Abbasgholizadeh, R.; Abbasian, M.; Abbastabar, H.; Abd Al Magied, A.H.; Abd ElHafeez, S.; Abdelkader, A. Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet. 2024;403:2204\u20132256.","DOI":"10.1016\/S0140-6736(24)00685-8"},{"key":"3472_CR2","doi-asserted-by":"publisher","first-page":"1183236","DOI":"10.3389\/fmicb.2023.1183236","volume":"14","author":"P Behzadi","year":"2023","unstructured":"Behzadi P, Garc\u00eda-Perdomo HA, Autr\u00e1n G\u00f3mez AM, Pinheiro M, Sarshar M. Uropathogens, urinary tract infections, the host-pathogen interactions and treatment. Front Microbiol. 2023;14:1183236.","journal-title":"Front Microbiol"},{"key":"3472_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2174\/1381612825999190619130216","volume":"25","author":"L Issakhanian","year":"2019","unstructured":"Issakhanian L, Behzadi P. Antimicrobial agents and urinary tract infections. Curr Pharm Des. 2019;25:1409\u201323.","journal-title":"Curr Pharm Des"},{"key":"3472_CR4","unstructured":"Behzadi, P., Behzadi, E. The microbial agents of urinary tract infections at central laboratory of Dr. Shariati Hospital, Tehran, Iran. Turk Klin Tip Bilim. 2008;28:445\u2013449."},{"key":"3472_CR5","doi-asserted-by":"publisher","unstructured":"Yazdansetad S, Alkhudhairy MK, Najafpour R, Farajtabrizi E, Al-Mosawi RM, Saki M, Jafarzadeh E, Izadpour F, Ameri A. Preliminary survey of extended-spectrum \u03b2-lactamases (ESBLs) in nosocomial uropathogen Klebsiella pneumoniae in north-central Iran. Heliyon. 2019;5(9):e02349. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02349.","DOI":"10.1016\/j.heliyon.2019.e02349"},{"key":"3472_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12223-019-00719-x","volume":"65","author":"P Behzadi","year":"2020","unstructured":"Behzadi P. Classical chaperone-usher (CU) adhesive fimbriome: uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs). Folia Microbiol. 2020;65:45\u201365.","journal-title":"Folia Microbiol"},{"key":"3472_CR7","doi-asserted-by":"publisher","unstructured":"Behzadi P, Behzadi E, Pawlak-Adamska EA. Urinary tract infections (UTIs) or genital tract infections (GTIs)? It's the diagnostics that count. GMS Hyg Infect Control. 2019;14:Doc14. https:\/\/doi.org\/10.3205\/dgkh000320.","DOI":"10.3205\/dgkh000320"},{"key":"3472_CR8","doi-asserted-by":"crossref","unstructured":"Barrios-Villa E, Pic\u00f3n LR, Reynaga RB, Arenas-Hern\u00e1ndez MM. An updated overview on the resistance and virulence of UPEC. Trending Topics in Escherichia coli Research: The Latin American Perspective. 2023:249\u201376.","DOI":"10.1007\/978-3-031-29882-0_11"},{"key":"3472_CR9","doi-asserted-by":"crossref","unstructured":"Behzadi P, Behzadi E. Uropathogenic Escherichia coli: An ideal resource for DNA microarray probe designing. In Proceedings of the Bioinformatics and Biomedical Engineering: 5th International Work-Conference, IWBBIO 2017, Granada, Spain, April 26\u201328, 2017, Proceedings, Part II 5, 2017; pp. 12\u201319.","DOI":"10.1007\/978-3-319-56154-7_2"},{"key":"3472_CR10","first-page":"452","volume":"68","author":"N Jahandeh","year":"2015","unstructured":"Jahandeh N, Ranjbar R, Behzadi P, Behzadi E. Uropathogenic Escherichia coli virulence genes: invaluable approaches for designing DNA microarray probes. CEJU. 2015;68:452\u20138.","journal-title":"CEJU"},{"key":"3472_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12929-022-00848-5","volume":"29","author":"T Kudinha","year":"2022","unstructured":"Kudinha T, Kong F. Distribution of papG alleles among uropathogenic Escherichia coli from reproductive age women. J Biomed Sci. 2022;29:66.","journal-title":"J Biomed Sci"},{"key":"3472_CR12","doi-asserted-by":"publisher","first-page":"1340427","DOI":"10.3389\/fmicb.2023.1340427","volume":"14","author":"MA Flores-Oropeza","year":"2024","unstructured":"Flores-Oropeza MA, Ochoa SA, Cruz-C\u00f3rdova A, Chavez-Tepecano R, Mart\u00ednez-Pe\u00f1afiel E, Rembao-Boj\u00f3rquez D, Zavala-Vega S, Hern\u00e1ndez-Castro R, Flores-Encarnacion M, Arellano-Galindo J. Comparative genomic analysis of uropathogenic Escherichia coli strains from women with recurrent urinary tract infection. Front Microbiol. 2024;14:1340427.","journal-title":"Front Microbiol"},{"key":"3472_CR13","doi-asserted-by":"publisher","unstructured":"Bu F, Dee DR, Liu B. Structural insight into Escherichia coli CsgA amyloid fibril assembly. mBio. 2024;15(4):e0041924. https:\/\/doi.org\/10.1128\/mbio.00419-24. Epub 2024 Mar 19.","DOI":"10.1128\/mbio.00419-24"},{"key":"3472_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1128\/MMBR.00013-14","volume":"78","author":"D Lebeaux","year":"2014","unstructured":"Lebeaux D, Ghigo J-M, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev. 2014;78:510\u201343.","journal-title":"Microbiol Mol Biol Rev"},{"key":"3472_CR15","first-page":"10","volume":"2","author":"S Baby","year":"2016","unstructured":"Baby S, Karnaker VK, Geetha R. Adhesins of uropathogenic Escherichia coli (UPEC). Int J Med Microbiol Trop Dis. 2016;2:10\u20138.","journal-title":"Int J Med Microbiol Trop Dis"},{"key":"3472_CR16","doi-asserted-by":"crossref","unstructured":"Chahales P, Thanassi DG. Structure, function, and assembly of adhesive organelles by uropathogenic bacteria. Urinary Tract Infections: Molecular Pathogenesis and Clinical Management. 2017;277\u2013329.","DOI":"10.1128\/9781555817404.ch14"},{"key":"3472_CR17","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1128\/jb.171.3.1262-1270.1989","volume":"171","author":"G-F Gerlach","year":"1989","unstructured":"Gerlach G-F, Clegg S, Allen BL. Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae. J Bacteriol. 1989;171:1262\u201370.","journal-title":"J Bacteriol"},{"key":"3472_CR18","doi-asserted-by":"publisher","first-page":"100881","DOI":"10.1016\/j.mgene.2021.100881","volume":"28","author":"MS Khonsari","year":"2021","unstructured":"Khonsari MS, Behzadi P, Foroohi F. The prevalence of type 3 fimbriae in Uropathogenic Escherichia coli isolated from clinical urine samples. Meta Gene. 2021;28:100881.","journal-title":"Meta Gene"},{"key":"3472_CR19","doi-asserted-by":"crossref","unstructured":"Ong, C.-l.Y.; Beatson, S.A.; Totsika, M.; Forestier, C.; McEwan, A.G.; Schembri, M.A. Molecular analysis of type 3 fimbrial genes from Escherichia coli, Klebsiella and Citrobacter species. BMC Microbiology. 2010;10:1\u201312.","DOI":"10.1186\/1471-2180-10-183"},{"key":"3472_CR20","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1128\/JB.01523-07","volume":"190","author":"C-LY Ong","year":"2008","unstructured":"Ong C-LY, Ulett GC, Mabbett AN, Beatson SA, Webb RI, Monaghan W, Nimmo GR, Looke DF, McEwan AG, Schembri MA. Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation. J Bacteriol. 2008;190:1054\u201363.","journal-title":"J Bacteriol"},{"key":"3472_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/B978-0-12-397048-0.00009-7","volume-title":"Uropathogenic escherichia coli","author":"RR Spurbeck","year":"2013","unstructured":"Spurbeck RR, Mobley HL. Uropathogenic escherichia coli. In Escherichia coli: Elsevier; 2013. p. 275\u2013304."},{"key":"3472_CR22","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1758-2229.2010.00166.x","volume":"2","author":"P Klemm","year":"2010","unstructured":"Klemm P, Hancock V, Schembri MA. Fimbrial adhesins from extraintestinal Escherichia coli. Environmental microbiology reports. 2010;2:628\u201340.","journal-title":"Environmental microbiology reports"},{"key":"3472_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13073-023-01243-x","volume":"15","author":"A Cu\u00e9nod","year":"2023","unstructured":"Cu\u00e9nod A, Agnetti J, Seth-Smith HM, Roloff T, W\u00e4lchli D, Shcherbakov D, Akbergenov R, Tschudin-Sutter S, Bassetti S, Siegemund M. Bacterial genome-wide association study substantiates papGII of Escherichia coli as a major risk factor for urosepsis. Genome Medicine. 2023;15:89.","journal-title":"Genome Medicine"},{"key":"3472_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1128\/CDLI.8.3.637-640.2001","volume":"8","author":"SD Manning","year":"2001","unstructured":"Manning SD, Zhang L, Foxman B, Spindler A, Tallman P, Marrs CF. Prevalence of known P-fimbrial G alleles in Escherichia coli and identification of a new adhesin class. Clinical Diagnostic Laboratory Immunology. 2001;8:637\u201340.","journal-title":"Clinical Diagnostic Laboratory Immunology"},{"key":"3472_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13353-020-00542-y","volume":"61","author":"A Hozzari","year":"2020","unstructured":"Hozzari A, Behzadi P, Kerishchi Khiabani P, Sholeh M, Sabokroo N. Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli. J Appl Genet. 2020;61:265\u201373.","journal-title":"J Appl Genet"},{"key":"3472_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/1874285801711010330","volume":"11","author":"R Ranjbar","year":"2017","unstructured":"Ranjbar R, Behzadi P, Najafi A, Roudi R. DNA microarray for rapid detection and identification of food and water borne bacteria: from dry to wet lab. The open microbiology journal. 2017;11:330.","journal-title":"The open microbiology journal"},{"key":"3472_CR27","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 31st ed. 2021."},{"key":"3472_CR28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/QCO.0000000000000966","volume":"36","author":"F Cosentino","year":"2023","unstructured":"Cosentino F, Viale P, Giannella M. MDR\/XDR\/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa? Curr Opin Infect Dis. 2023;36:564\u201371.","journal-title":"Curr Opin Infect Dis"},{"key":"3472_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A-P Magiorakos","year":"2012","unstructured":"Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas M, Giske CG, Harbarth S, Hindler J, Kahlmeter G, Olsson-Liljequist B. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"3472_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00240-012-0499-6","volume":"40","author":"D Wojnicz","year":"2012","unstructured":"Wojnicz D, Kucharska AZ, Sok\u00f3\u0142-\u0141\u0119towska A, Kicia M, Tichaczek-Goska D. Medicinal plants extracts affect virulence factors expression and biofilm formation by the uropathogenic Escherichia coli. Urol Res. 2012;40:683\u201397.","journal-title":"Urol Res"},{"key":"3472_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3168\/jds.2010-3435","volume":"94","author":"E Khafipour","year":"2011","unstructured":"Khafipour E, Plaizier J, Aikman PC, Krause D. Population structure of rumen Escherichia coli associated with subacute ruminal acidosis (SARA) in dairy cattle. J Dairy Sci. 2011;94:351\u201360.","journal-title":"J Dairy Sci"},{"key":"3472_CR32","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/S0022-5347(05)65644-3","volume":"166","author":"C-C Tseng","year":"2001","unstructured":"Tseng C-C, Huang J-J, Ko W-C, Yan J-J, Wu J-J. Decreased predominance of papG class II allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities. J Urol. 2001;166:1643\u20136.","journal-title":"J Urol"},{"key":"3472_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1574-695X.1998.tb01173.x","volume":"21","author":"K Mitsumori","year":"1998","unstructured":"Mitsumori K, Terai A, Yamamoto S, Yoshida O. Identification of S, F1C and three PapG fimbrial adhesins in uropathogenic Escherichia coli by polymerase chain reaction. FEMS Immunol Med Microbiol. 1998;21:261\u20138.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"3472_CR34","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1128\/iai.65.6.2153-2159.1997","volume":"65","author":"JR Johnson","year":"1997","unstructured":"Johnson JR, Stapleton AE, Russo TA, Scheutz F, Brown JJ, Maslow JN. Characteristics and prevalence within serogroup O4 of a J96-like clonal group of uropathogenic Escherichia coli O4: H5 containing the class I and class III alleles of papG. Infect Immun. 1997;65:2153\u20139.","journal-title":"Infect Immun"},{"key":"3472_CR35","first-page":"105","volume":"69","author":"P Behzadi","year":"2016","unstructured":"Behzadi P, Najafi A, Behzadi E, Ranjbar R. Microarray long oligo probe designing for Escherichia coli: an in-silico DNA marker extraction. CEJU. 2016;69:105\u201311.","journal-title":"CEJU"},{"key":"3472_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/antibiotics13030257","volume":"13","author":"T Karampatakis","year":"2024","unstructured":"Karampatakis T, Tsergouli K, Behzadi P. Pan-Genome Plasticity and Virulence Factors: A Natural Treasure Trove for Acinetobacter baumannii. Antibiotics. 2024;13:257.","journal-title":"Antibiotics"},{"key":"3472_CR37","first-page":"35","volume":"15","author":"P Behzadi","year":"2021","unstructured":"Behzadi P, Urb\u00e1n E, Matuz M, Benk\u0151 R, Gajd\u00e1cs M. The role of gram-negative bacteria in urinary tract infections: current concepts and therapeutic options. Advances in Microbiology, Infectious Diseases and Public Health: 2021;15:35\u201369.","journal-title":"Advances in Microbiology, Infectious Diseases and Public Health:"},{"key":"3472_CR38","doi-asserted-by":"publisher","first-page":"16457","DOI":"10.1038\/s41598-019-52859-2","volume":"9","author":"NM Mbelle","year":"2019","unstructured":"Mbelle NM, Feldman C, OseiSekyere J, Maningi NE, Modipane L, Essack SY. The resistome, mobilome virulome and phylogenomics of multidrug-resistant Escherichia coli clinical isolates from Pretoria South Africa. Scientific Reports. 2019;9:16457.","journal-title":"Scientific Reports."},{"key":"3472_CR39","doi-asserted-by":"crossref","unstructured":"Behzadi, P.; Dodero, V.I.; Golubnitschaja, O. Systemic Inflammation as the Health-Related Communication Tool Between the Human Host and Gut Microbiota in the Framework of Predictive, Preventive, and Personalized Medicine. In All Around Suboptimal Health: Advanced Approaches by Predictive, Preventive and Personalised Medicine for Healthy Populations; Springer: 2024; pp. 203\u2013241.","DOI":"10.1007\/978-3-031-46891-9_15"},{"key":"3472_CR40","doi-asserted-by":"crossref","unstructured":"Behzadi P. \"The role of Toll-like receptor (TLR) polymorphisms in urinary bladder cancer.\" Genetic Polymorphism and cancer susceptibility. 2021:281\u2013317.","DOI":"10.1007\/978-981-33-6699-2_9"},{"key":"3472_CR41","first-page":"379","volume-title":"Toll-like receptor (TLR) polymorphisms in prostate cancer","author":"P Behzadi","year":"2022","unstructured":"Behzadi P. Toll-like receptor (TLR) polymorphisms in prostate cancer. In Genetic Polymorphism and Disease: CRC Press; 2022. p. 379\u201399."},{"key":"3472_CR42","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/antibiotics9070397","volume":"9","author":"M Sarshar","year":"2020","unstructured":"Sarshar M, Behzadi P, Ambrosi C, Zagaglia C, Palamara AT, Scribano D. FimH and anti-adhesive therapeutics: a disarming strategy against uropathogens. Antibiotics. 2020;9:397.","journal-title":"Antibiotics"},{"key":"3472_CR43","doi-asserted-by":"publisher","first-page":"1135614","DOI":"10.3389\/fmicb.2023.1135614","volume":"14","author":"A Algammal","year":"2023","unstructured":"Algammal A, Hetta HF, Mabrok M, Behzadi P. Emerging multidrug-resistant bacterial pathogens \u201csuperbugs\u201d: A rising public health threat. Front Microbiol. 2023;14:1135614.","journal-title":"Front Microbiol"},{"key":"3472_CR44","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/ndt\/gfad233","volume":"39","author":"S Von Vietinghoff","year":"2024","unstructured":"Von Vietinghoff S, Shevchuk O, Dobrindt U, Engel DR, Jorch SK, Kurts C, Miethke T, Wagenlehner F. The global burden of antimicrobial resistance\u2013urinary tract infections. Nephrol Dial Transplant. 2024;39:581\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"3472_CR45","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1007\/s11033-020-05651-9","volume":"47","author":"P Behzadi","year":"2020","unstructured":"Behzadi P, Garc\u00eda-Perdomo HA, Karpi\u0144ski TM, Issakhanian L. Metallo-\u00df-lactamases: a review. Mol Biol Rep. 2020;47:6281\u201394.","journal-title":"Mol Biol Rep"},{"key":"3472_CR46","doi-asserted-by":"publisher","first-page":"975616","DOI":"10.3389\/fmicb.2022.975616","volume":"13","author":"P Behzadi","year":"2022","unstructured":"Behzadi P, Ambrosi C, Scribano D, Zanetti S, Sarshar M, Gajd\u00e1cs M, Donadu MG. Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens. Front Microbiol. 2022;13:975616.","journal-title":"Front Microbiol"},{"key":"3472_CR47","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.2147\/IDR.S391378","volume":"16","author":"SA Fonseca-Mart\u00ednez","year":"2023","unstructured":"Fonseca-Mart\u00ednez SA, Mart\u00ednez-Vega RA, Farf\u00e1n-Garc\u00eda AE, Gonz\u00e1lez Rugeles CI, Criado-Guerrero LY. Association Between Uropathogenic Escherichia coli Virulence Genes and Severity of Infection and Resistance to Antibiotics. Infect Drug Resist. 2023;16:3707\u201318.","journal-title":"Infect Drug Resist."},{"key":"3472_CR48","doi-asserted-by":"publisher","first-page":"105493","DOI":"10.1016\/j.meegid.2023.105493","volume":"114","author":"M-C Wang","year":"2023","unstructured":"Wang M-C, Fan Y-H, Zhang Y-Z, Bregente CJB, Lin W-H, Chen C-A, Lin T-P, Kao C-Y. Characterization of uropathogenic Escherichia coli phylogroups associated with antimicrobial resistance, virulence factor distribution, and virulence-related phenotypes. Infect Genet Evol. 2023;114:105493.","journal-title":"Infect Genet Evol"},{"key":"3472_CR49","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1017\/ash.2022.340","volume":"3","author":"S D\u2019Incau","year":"2023","unstructured":"D\u2019Incau S, Atkinson A, Leitner L, Kronenberg A, Kessler TM, Marschall J. Bacterial species and antimicrobial resistance differ between catheter and non\u2013catheter-associated urinary tract infections: Data from a national surveillance network. Antimicrobial Stewardship & Healthcare Epidemiology. 2023;3:e55.","journal-title":"Antimicrobial Stewardship & Healthcare Epidemiology"},{"key":"3472_CR50","doi-asserted-by":"publisher","first-page":"105256","DOI":"10.1016\/j.micpath.2021.105256","volume":"161","author":"SD Mitra","year":"2021","unstructured":"Mitra SD, Irshad P, Anusree M, Rekha I, Shailaja S, Suresh J, Aishwarya G, Shrestha S, Shome BR. Whole genome global insight of antibiotic resistance gene repertoire and virulome of high-risk multidrug-resistant Uropathogenic Escherichia coli. Microb Pathog. 2021;161:105256.","journal-title":"Microb Pathog"},{"key":"3472_CR51","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3390\/microorganisms11092169","volume":"11","author":"S Whelan","year":"2023","unstructured":"Whelan S, Lucey B, Finn K. Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment. Microorganisms. 2023;11:2169.","journal-title":"Microorganisms"},{"key":"3472_CR52","doi-asserted-by":"publisher","first-page":"1244345","DOI":"10.3389\/fimmu.2023.1244345","volume":"14","author":"S Mukherjee","year":"2023","unstructured":"Mukherjee S, Patra R, Behzadi P, Masotti A, Paolini A, Sarshar M. Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives. Front Immunol. 2023;14:1244345.","journal-title":"Front Immunol"},{"key":"3472_CR53","first-page":"404","volume":"69","author":"E Behzadi","year":"2016","unstructured":"Behzadi E, Behzadi P. The role of toll-like receptors (TLRs) in urinary tract infections (UTIs). CEJU. 2016;69:404\u201310.","journal-title":"CEJU"},{"key":"3472_CR54","doi-asserted-by":"publisher","first-page":"2054431","DOI":"10.1155\/2022\/2054431","volume":"2022","author":"P Behzadi","year":"2022","unstructured":"Behzadi P, Sameer AS, Nissar S, Banday MZ, Gajd\u00e1cs M, Garc\u00eda-Perdomo HA, Akhtar K, Pinheiro M, Magnusson P, Sarshar M. The Interleukin-1 (IL-1) superfamily cytokines and their single nucleotide polymorphisms (SNPs). J Immunol Res. 2022;2022:2054431.","journal-title":"J Immunol Res."},{"key":"3472_CR55","doi-asserted-by":"publisher","first-page":"1294869","DOI":"10.3389\/fimmu.2023.1294869","volume":"14","author":"P Behzadi","year":"2023","unstructured":"Behzadi P, Kim C-H, Pawlak EA, Algammal A. The innate and adaptive immune system in human urinary system. Front Immunol. 2023;14:1294869.","journal-title":"Front Immunol"},{"key":"3472_CR56","doi-asserted-by":"publisher","first-page":"e22647","DOI":"10.5812\/jjm.22647","volume":"8","author":"M Rahdar","year":"2015","unstructured":"Rahdar M, Rashki A, Miri HR, Ghalehnoo MR. Detection of pap, sfa, afa, foc, and fim adhesin-encoding operons in uropathogenic Escherichia coli isolates collected from patients with urinary tract infection. Jundishapur J Microbiol. 2015;8:e22647.","journal-title":"Jundishapur J Microbiol"},{"key":"3472_CR57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jhin.2021.08.017","volume":"117","author":"Z Naziri","year":"2021","unstructured":"Naziri Z, Kilegolan J, Moezzi M, Derakhshandeh A. Biofilm formation by uropathogenic Escherichia coli: a complicating factor for treatment and recurrence of urinary tract infections. J Hosp Infect. 2021;117:9\u201316.","journal-title":"J Hosp Infect"},{"key":"3472_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.29252\/mlj.12.5.10","volume":"12","author":"M Yazdi","year":"2018","unstructured":"Yazdi M, Bouzari M, Ghaemi EA. Detection of fim, pap, sfa and afa adhesin-encoding operons in Escherichia coli strains isolated from urinary tract infections. Medical Laboratory Journal. 2018;12:10\u20135.","journal-title":"Medical Laboratory Journal"},{"key":"3472_CR59","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1007\/s00284-020-02173-2","volume":"77","author":"R Baldiris-Avila","year":"2020","unstructured":"Baldiris-Avila R, Montes-Robledo A, Buelvas-Montes Y. Phylogenetic classification, biofilm-forming capacity, virulence factors, and antimicrobial resistance in uropathogenic Escherichia coli (UPEC). Curr Microbiol. 2020;77:3361\u201370.","journal-title":"Curr Microbiol"},{"key":"3472_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-10-179","volume":"10","author":"C Schroll","year":"2010","unstructured":"Schroll C, Barken KB, Krogfelt KA, Struve C. Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation. BMC Microbiol. 2010;10:1\u201310.","journal-title":"BMC Microbiol"},{"key":"3472_CR61","first-page":"1098","volume":"24","author":"FM Zadeh","year":"2021","unstructured":"Zadeh FM, Zarei H, Jahromy SH. Type1 and 3 fimbriae phenotype and genotype as suitable markers for uropathogenic bacterial pathogenesis via attachment, cell surface hydrophobicity, and biofilm formation in catheter-associated urinary tract infections (CAUTIs). Iran J Basic Med Sci. 2021;24:1098.","journal-title":"Iran J Basic Med Sci"},{"key":"3472_CR62","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3343\/alm.2022.42.2.203","volume":"42","author":"B Kim","year":"2022","unstructured":"Kim B, Kim J-H, Lee Y. Virulence factors associated with Escherichia coli bacteremia and urinary tract infection. Ann Lab Med. 2022;42:203.","journal-title":"Ann Lab Med"},{"key":"3472_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/microorganisms10010005","volume":"10","author":"H Bessaiah","year":"2021","unstructured":"Bessaiah H, Anamal\u00e9 C, Sung J, Dozois CM. What flips the switch? Signals and stress regulating extraintestinal pathogenic Escherichia coli type 1 fimbriae (pili). Microorganisms. 2021;10:5.","journal-title":"Microorganisms"},{"key":"3472_CR64","doi-asserted-by":"publisher","first-page":"101622","DOI":"10.1016\/j.genrep.2022.101622","volume":"27","author":"F Firoozeh","year":"2022","unstructured":"Firoozeh F, Zibaei M, Badmasti F, Khaledi A. Virulence factors, antimicrobial resistance and the relationship between these characteristics in uropathogenic Escherichia coli. Gene Reports. 2022;27:101622.","journal-title":"Gene Reports"},{"key":"3472_CR65","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00294-015-0529-3","volume":"62","author":"S Khandige","year":"2016","unstructured":"Khandige S, M\u00f8ller-Jensen J. Fimbrial phase variation: stochastic or cooperative? Curr Genet. 2016;62:237\u201341.","journal-title":"Curr Genet"},{"key":"3472_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06036-4","volume":"21","author":"SE Rezatofighi","year":"2021","unstructured":"Rezatofighi SE, Mirzarazi M, Salehi M. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: a case-control study. BMC Infect Dis. 2021;21:1\u201311.","journal-title":"BMC Infect Dis"},{"key":"3472_CR67","doi-asserted-by":"publisher","first-page":"e61169","DOI":"10.1371\/journal.pone.0061169","volume":"8","author":"X Qin","year":"2013","unstructured":"Qin X, Hu F, Wu S, Ye X, Zhu D, Zhang Y, Wang M. Comparison of adhesin genes and antimicrobial susceptibilities between uropathogenic and intestinal commensal Escherichia coli strains. PLoS ONE. 2013;8:e61169.","journal-title":"PLoS ONE"},{"key":"3472_CR68","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.bjm.2016.01.024","volume":"47","author":"MA Cordeiro","year":"2016","unstructured":"Cordeiro MA, Werle CH, Milanez GP, Yano T. Curli fimbria: an Escherichia coli adhesin associated with human cystitis. Braz J Microbiol. 2016;47:414\u20136.","journal-title":"Braz J Microbiol."},{"key":"3472_CR69","doi-asserted-by":"publisher","first-page":"e51274","DOI":"10.1371\/journal.pone.0051274","volume":"7","author":"MS Dueholm","year":"2012","unstructured":"Dueholm MS, Albertsen M, Otzen D, Nielsen PH. Curli functional amyloid systems are phylogenetically widespread and display large diversity in operon and protein structure. PLoS ONE. 2012;7:e51274.","journal-title":"PLoS ONE"},{"key":"3472_CR70","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev.micro.60.080805.142106","volume":"60","author":"MM Barnhart","year":"2006","unstructured":"Barnhart MM, Chapman MR. Curli biogenesis and function. Annu Rev Microbiol. 2006;60:131\u201347.","journal-title":"Annu Rev Microbiol"},{"key":"3472_CR71","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1126\/science.1067484","volume":"295","author":"MR Chapman","year":"2002","unstructured":"Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, Normark S, Hultgren SJ. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science. 2002;295:851\u20135.","journal-title":"Science"},{"key":"3472_CR72","doi-asserted-by":"publisher","first-page":"2300234","DOI":"10.1002\/mabi.202300234","volume":"24","author":"M Siri","year":"2024","unstructured":"Siri M, Mangiarotti A, V\u00e1zquez-D\u00e1vila M, Bidan CM. Curli amyloid fibers in Escherichia coli biofilms: the influence of water availability on their structure and functional properties. Macromolecular Bioscience. 2024;24:2300234.","journal-title":"Macromolecular Bioscience"},{"key":"3472_CR73","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eursup.2016.04.003","volume":"15","author":"R Bartoletti","year":"2016","unstructured":"Bartoletti R, Cai T, Wagenlehner FM, Naber K, Johansen TEB. Treatment of urinary tract infections and antibiotic stewardship. Eur Urol Suppl. 2016;15:81\u20137.","journal-title":"Eur Urol Suppl"},{"key":"3472_CR74","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3389\/fmicb.2020.01509","volume":"11","author":"P Loubet","year":"2020","unstructured":"Loubet P, Ranfaing J, Dinh A, Dunyach-Remy C, Bernard L, Bruy\u00e8re F, Lavigne J-P, Sotto A. Alternative therapeutic options to antibiotics for the treatment of urinary tract infections. Front Microbiol. 2020;11:1509.","journal-title":"Front Microbiol"},{"key":"3472_CR75","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3390\/microorganisms10071425","volume":"10","author":"C Zagaglia","year":"2022","unstructured":"Zagaglia C, Ammendolia MG, Maurizi L, Nicoletti M, Longhi C. Urinary tract infections caused by uropathogenic Escherichia coli strains\u2014new strategies for an old pathogen. Microorganisms. 2022;10:1425.","journal-title":"Microorganisms"},{"key":"3472_CR76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1024\/0300-9831\/a000704","volume":"91","author":"D Scribano","year":"2021","unstructured":"Scribano D, Sarshar M, Fettucciari L, Ambrosi C. Urinary tract infections: Can we prevent uropathogenic Escherichia coli infection with dietary intervention? Int J Vitam Nutr Res. 2021;91:391\u20135.","journal-title":"Int J Vitam Nutr Res."}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03472-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-024-03472-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-024-03472-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T04:02:52Z","timestamp":1726286572000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-024-03472-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,14]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3472"],"URL":"https:\/\/doi.org\/10.1186\/s12866-024-03472-5","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,14]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This scientific investigation has been performed under the permission number of DP\/97\/220 (97\/12\/12), issued by the Research Council of the Islamic Azad University, Shahr-e-Qods Branch. Since, the urine samples and the related information in association with the patients with UTIs were enrolled by the Labs\u2019 and hospital\u2019s technicians and experts and all these materials were anonymous to the authors, no ethical approval was needed for this project. This study was achieved according to the Declaration of Helsinki guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Payam BEHZADI is the BMC Microbiology Editorial Board Member.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}